These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 30370598
1. High blood lead concentrations in captive Tasmanian devils (Sarcophilus harrisii): a threat to the conservation of the species? Hivert LG, Clarke JR, Peck SJ, Lawrence C, Brown WE, Huxtable SJ, Schaap D, Pemberton D, Grueber CE. Aust Vet J; 2018 Nov; 96(11):442-449. PubMed ID: 30370598 [Abstract] [Full Text] [Related]
3. Causes of mortality and severe morbidity requiring euthanasia in captive Tasmanian devils (Sarcophilus harrisii) in Tasmania. Peck SJ, Michael SA, Knowles G, Davis A, Pemberton D. Aust Vet J; 2019 Apr; 97(4):89-92. PubMed ID: 30919442 [Abstract] [Full Text] [Related]
14. Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor (DFT) as it spreads through the wild Tasmanian devil population. Pearse AM, Swift K, Hodson P, Hua B, McCallum H, Pyecroft S, Taylor R, Eldridge MD, Belov K. Cancer Genet; 2012 Mar 01; 205(3):101-12. PubMed ID: 22469509 [Abstract] [Full Text] [Related]
15. Lead exposure and source attribution for a mammalian scavenger before and after a culling program. Jones EM, Koch AJ, Pay JM, Jones ME, Hamede RK, Hampton JO. Sci Total Environ; 2024 Aug 25; 940():173686. PubMed ID: 38830425 [Abstract] [Full Text] [Related]
16. The Tasmanian devil microbiome-implications for conservation and management. Cheng Y, Fox S, Pemberton D, Hogg C, Papenfuss AT, Belov K. Microbiome; 2015 Dec 21; 3():76. PubMed ID: 26689946 [Abstract] [Full Text] [Related]
17. Pedigree analysis reveals a generational decline in reproductive success of captive Tasmanian devil (Sarcophilus harrisii): implications for captive management of threatened species. Farquharson KA, Hogg CJ, Grueber CE. J Hered; 2017 Jul 01; 108(5):488-495. PubMed ID: 28379457 [Abstract] [Full Text] [Related]
19. Doxorubicin and carboplatin trials in Tasmanian devils (Sarcophilus harrisii) with Tasmanian devil facial tumor disease. Phalen DN, Frimberger AE, Peck S, Pyecroft S, Harmsen C, Lola S, Moore AS. Vet J; 2015 Dec 01; 206(3):312-6. PubMed ID: 26538144 [Abstract] [Full Text] [Related]
20. Diversity in the Toll-like receptor genes of the Tasmanian devil (Sarcophilus harrisii). Cui J, Cheng Y, Belov K. Immunogenetics; 2015 Mar 01; 67(3):195-201. PubMed ID: 25563844 [Abstract] [Full Text] [Related] Page: [Next] [New Search]